Teleallergy: Where Have We Been and Where Are We Going?

Authors

Allison Ramsey, Rochester Regional HealthFollow
Ann Chen Wu, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Mass.
Bruce G. Bender, National Jewish Health, Denver, Colo.
Jay Portnoy, Children's Mercy Hospital, Kansas City, Mo.

Department

Allergy and Immunology

Document Type

Article

Publication Title

The Journal of Allergy and Clinical Immunology. In Practice

Abstract

Telemedicine uptake in allergy/immunology was slow before the coronavirus disease 2019 pandemic, but has accelerated since. This review examines where telemedicine has been in allergy/immunology and where it is headed in the future. Focus is placed on patient, physician, and health care professional satisfaction with telemedicine, capacity to expand access to allergy/immunology care, cost considerations, the regulatory environment, and future applications of telemedicine including adherence monitoring, wearable biosensors, artificial intelligence, and machine learning addressed.

First Page

126

Last Page

131

DOI

10.1016/j.jaip.2022.08.032

Volume

11

Issue

1

Publication Date

1-1-2023

PubMed ID

36064184

Recommended Citation

Ramsey, A., Wu, A. C., Bender, B. G., & Portnoy, J. (2023). Teleallergy: Where Have We Been and Where Are We Going?. The Journal of Allergy and Clinical Immunology. In Practice, 11 (1), 126-131. https://doi.org/10.1016/j.jaip.2022.08.032